Month: August 2022
PRESS RELEASE
25/08/2022
Acceleration of revenue growth in the 2nd quarter:
+36.2% (+8.1% at constant scope)
Revenue in the 1st half-year up by 32.8% (+3.7% at constant scope)
Annual objectives confirmed
Satisfactory revenue for the 1st half-year, in line with expectations
LACROIX’s revenue in the 2nd quarter amounted to €173.2 million – an increase of 36.2% compared with the 2nd quarter of 2021, and an acceleration in growth compared with the 1st quarter of 2022 (+29.4%). At constant scope, LACROIX recorded a growth in revenue of 8.1%. This growth is mainly due to the continuation of good market momentum for the Environment Activity and Electronics Activity, and the impact of passing on the increase in procurement costs for certain components in selling prices.
In line with expectations, LACROIX recorded...
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2022
Written by Customer Service on . Posted in Public Companies.
Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2022
(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Charenton-le-Pont, France (August 25, 2022 – 6:00 pm) – As of July 31, 2022, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.
July 31, 2022Shares outstanding
447,420,4191Number of real voting rights (excluding treasury shares)
443,676,730Theoretical number of voting rights (including treasury shares)
447,420,419It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained...
Andes Technology USA Corp. to Host First Virtual Career Event Seeking RISC-V Talent to Grow Its North America Operation
Written by Customer Service on . Posted in Public Companies.
SAN JOSE, Aug. 25, 2022 (GLOBE NEWSWIRE) — Andes Technology USA Corporation, the headquarters of North America operations of Hsinchu, Taiwan-based Andes Technology Corporation, a leading supplier of high efficiency, low-power 32/64-bit RISC-V processor cores and Founding Premier member of RISC-V International, today announced its first Virtual Career Event to grow it R&D facilities in North America. With a significant headcount growth of over 350% in the past year, Andes Technology USA continues to expand its North American presence. The company is hiring engineers to work remotely as well as in its three west coast North America offices. Andes will host its first Virtual Career Event on September 8th. All levels of engineers with an interest in CPU, microarchitecture, RTL, or pre-silicon verification are encouraged to attend.
As...
Egide: Appointment of Terry TOH as the new manager of the Cambridge facility (Maryland, USA).
Written by Customer Service on . Posted in Public Companies.
Bollène, August 25, 2022 – 06 :00 pm (CET)Press Release
Appointment of Terry TOH as the new manager of the Cambridge facility (Maryland, USA).
The Egide Group (Euronext Paris™- Compartment C – ISIN: FR0000072373) announces the appointment of Terry TOH as manager of the Cambridge facility.
He succeeds Kirk WILLIAMSON, who has decided to pursue his career outside the Group.
This appointment is effective as of June 1, 2022.
Jim COLLINS, President and CEO of Egide Group, comments, “We are proud to announce the appointment of Terry TOH as the General Manager of the Cambridge facility. Terry comes to Egide with vast management experience in a manufacturing environment and has experience in marketing, sales, business development and engineering. We are fortunate to have someone with Terry’s experience to lead the Cambridge facility...
First Wave BioPharma, Inc. Announces Reverse Stock Split
Written by Customer Service on . Posted in Public Companies.
BOCA RATON, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 30 pre-split shares. First Wave’s common stock will continue to be traded on the NASDAQ Capital Market under the symbol FWBI and will begin trading on a split-adjusted basis when the market opens on Friday, August 26, 2022, under a new CUSIP number, 33749P200.
At the effective time of the reverse stock split, every thirty shares of First Wave’s issued and outstanding common stock will be converted automatically into one issued and...
Nuvei Releases Inaugural Environmental, Social and Governance Report
Written by Customer Service on . Posted in Public Companies.
Report highlights initiative to deliver long-term sustainable value for all stakeholders
MONTREAL, Aug. 25, 2022 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (Nasdaq: NVEI) (TSX: NVEI), tomorrow’s payment platform, announces the publication of its inaugural Environmental, Social, and Governance (“ESG”) report.
The report sets out Nuvei’s ongoing drive to build sustainable business practices to protect the environment, support the communities in which it operates and create value for employees, investors, and customers.
“Nuvei’s value creation story is simple: we only grow when our stakeholders thrive,” said Nuvei Chair and CEO Philip Fayer. “So, whether it is helping our customers accelerate their business, fostering an engaged and diverse workforce, supporting our local communities or achieving superior financial...
Deutsche Balaton Aktiengesellschaft Announces Filing of Early Warning Report
Written by Customer Service on . Posted in Mergers And Acquisitions.
HEIDELBERG, Germany, Aug. 25, 2022 (GLOBE NEWSWIRE) — Deutsche Balaton Aktiengesellschaft (“Deutsche Balaton”) and its Joint Actors acquired 5,267,539 Common Shares (“Shares”) of Elemental Royalties Corp. (“ELEMENTAL”) (TSX-V: ELE) in exchange for shares of Altus Strategies plc (“ALTUS”), representing 3.56% of the issued and outstanding Shares, by way of a scheme of arrangement pursuant to Part 26 of the Companies Act 2006 under the laws of the United Kingdom in exchange for common shares in the capital of ELEMENTAL (the “Merger”) pursuant to a cooperation agreement between ELEMENTAL and ALTUS dated June 14, 2022, as amended and restated June 21, 2022.
Immediately prior to the completion of the Merger, Deutsche Balaton and its Joint Actors held 8,400,000 Shares, representing 10.73% of the issued and outstanding Shares prior to...
Nasdaq Halts Smart Powerr Corp.
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Smart Powerr Corp. (Nasdaq: CREG) at 11:07:03 A.M. Eastern Time for “additional information requested” from the company at a last sale price of $3.5762.
Trading will remain halted until Smart Powerr Corp. has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
Nasdaq Media Contact:
Sophia Weisssophia.weiss@nasdaq.com
NDAQO
Nasdaq Halts Statera Biopharma, Inc.
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (Nasdaq: STAB) at 11:01:52 A.M. Eastern Time for “additional information requested” from the company at a last sale price of $0.215.
Trading will remain halted until Statera Biopharma, Inc. has fully satisfied Nasdaq’s request for additional information.
For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.
Nasdaq Media Contact:
Sophia Weisssophia.weiss@nasdaq.com
NDAQO
RAMSAY SANTE : Provisional annual Results at the end of June 2022
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
PRESS RELEASE
Paris, August 25, 2022
Provisional annual results at end June 2022
The solid performance of the Nordic countries has led to an improvement in the results of the Ramsay Santé group, despite the persistent challenges of high inflation, a shortage of nursing and clinical staff and the ongoing pandemic, in which Ramsay Santé has continued to play a leading role in Europe.
In line with its Yes We Care 2025 strategic plan, Ramsay Santé has continued to invest at a level comparable with previous years in order to consolidate its position with patients as a comprehensive and integrated healthcare player in continental Europe.With more than 10,000 COVID patients treated in France, including 4,500 in critical care, Ramsay Santé has maintained its commitment to combating COVID over the past 12 months. In Sweden, we have continued...
